LION bioscience AG erweitert Vorstand nach erfolgreich abgeschlossenem Erwerb der SYGNIS Bioscience GmbH & Co. KG
11-Oct-2006
Dr. Alfred Bach wird die Funktion des CEO, Peter Willinger die des CFO der LION bioscience AG übernehmen.
Organizations
Lion bioscience
SYGNIS Bioscience
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.